Matches in DBpedia 2014 for { ?s ?p Prof. Dr. Ralf M. Altmeyer is a German virologist who leads the Institut Pasteur of Shanghai, a joint institute of the Chinese Academy of Sciences, Institut Pasteur and Shanghai Municipal Government, founded in 2004.He completed his pre-doctoral studies at the State University of New York at Stony Brook, and holds a Ph. D. (1994) from Institut Pasteur in Paris, where he also completed his postdoctoral thesis on neuropathogenesis of HIV infections (1996).His research interests include respiratory diseases, Hepatitis C, HIV, and focus on anti-infective therapeutic strategies.During his career of fifteen years at Institut Pasteur and the Pasteur international network, Ralf Altmeyer held various management positions including the position of CEO of the HKU-Pasteur Research Centre in Hong Kong. From 2003 to 2006 Ralf Altmeyer was the architect of a successful restructuring and establishment of the organization’s new strategy.He left Institut Pasteur in 2006 to become the President of CombinatoRx-Singapore, the infectious disease subsidiary of CombinatoRx (NASDAQ:CRXX), established in 2005 in collaboration with Bio*One Capital in Singapore. Ralf Altmeyer left CombinatoRx-Singapore in summer 2009 subsequent to the acquisition of the company by Forma Therapeutics. In 2011, he founded Advance BioChina, a Shanghai-based incubator company that helps global biotech companies access the Chinese market [1].Ralf Altmeyer also holds the position of Adjunct Professor at Griffith University of Australia, Institute of Glycomics.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Ralf_Altmeyer abstract "Prof. Dr. Ralf M. Altmeyer is a German virologist who leads the Institut Pasteur of Shanghai, a joint institute of the Chinese Academy of Sciences, Institut Pasteur and Shanghai Municipal Government, founded in 2004.He completed his pre-doctoral studies at the State University of New York at Stony Brook, and holds a Ph. D. (1994) from Institut Pasteur in Paris, where he also completed his postdoctoral thesis on neuropathogenesis of HIV infections (1996).His research interests include respiratory diseases, Hepatitis C, HIV, and focus on anti-infective therapeutic strategies.During his career of fifteen years at Institut Pasteur and the Pasteur international network, Ralf Altmeyer held various management positions including the position of CEO of the HKU-Pasteur Research Centre in Hong Kong. From 2003 to 2006 Ralf Altmeyer was the architect of a successful restructuring and establishment of the organization’s new strategy.He left Institut Pasteur in 2006 to become the President of CombinatoRx-Singapore, the infectious disease subsidiary of CombinatoRx (NASDAQ:CRXX), established in 2005 in collaboration with Bio*One Capital in Singapore. Ralf Altmeyer left CombinatoRx-Singapore in summer 2009 subsequent to the acquisition of the company by Forma Therapeutics. In 2011, he founded Advance BioChina, a Shanghai-based incubator company that helps global biotech companies access the Chinese market [1].Ralf Altmeyer also holds the position of Adjunct Professor at Griffith University of Australia, Institute of Glycomics.".